vs IDMT 1.79 0.03 a.u
Ebben M, Lequerica A, Spielman A
it offers complementary benefits to aid in weight management
The use of DPP-4is as a comparator provided a highly comparable control group, particularly as both drugs were used in the setting of sole add-on medication to metformin, and both drugs have similar priority in the management of T2D
Many insurance plans cover FDA-approved semaglutide for weight management, particularly when prescribed for patients meeting specific BMI criteria or those with obesity-related comorbidities such as type 2 diabetes, hypertension, or dyslipidemia
However, it is noteworthy that a 26-week treatment of dulaglutide 1.5 mg or tirzepatide 5 mg showed comparable outcomes in improvements of MASH and liver fibrosis biomarkers, including liver enzymes, keratin-18, procollagen III, and adiponectin